Seyma Buyucek
Hamburg, HH 20246, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.
Journal: Frontiers in oncology
Published: February 12, 2026
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.
Prevalence and clinical significance of CBP deficiency and disturbed CBP expression in human cancer.
Journal: Experimental and molecular pathology
Published: July 23, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.
Journal: Diagnostics (Basel, Switzerland)
Published: April 11, 2025
L1CAM/CD171 expression in human tumors and its association with tumor phenotype.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 11, 2025
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy.
Journal: Neoplasia (New York, N.Y.)
Published: February 13, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.
Journal: PloS one
Published: December 11, 2024
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypes.
Journal: Annals of diagnostic pathology
Published: December 09, 2024
Last Updated: 09/26/2026